Medical Software Development

What Is Medical Software Development?

Medical software development covers software built for healthcare use, such as diagnostic algorithms or patient intake tools, developed under rules that protect patient safety and health data. When a product qualifies as a medical device, the team must also prove it is safe for the people it serves, and producing that proof adds cost and time to the project.

The term covers a wide range of products. At one end sits Software as a Medical Device (SaMD). The International Medical Device Regulators Forum defines it as software that serves a medical purpose on its own, without being part of a hardware device. Software that runs inside hardware is regulated as part of that device, and medical device software development covers the split between the two. At the other end sit administrative tools that may fall outside device rules entirely, such as appointment scheduling or patient intake software, which still handle protected health data.

In every case, the manufacturer's intended use determines how much regulation applies. Two products with near-identical code can land in different regulatory classes because one claims to support diagnosis and the other claims only to display data.

Why Does Healthcare Software Need a Regulated Development Process?

• Market access depends on the evidence file. US and EU regulators judge the product by its documentation file. A product that works perfectly but lacks a traceable record linking requirements to tests stalls in review, so the process turns working software into a sellable product.

• Software defects in healthcare reach patients. A rounding error in a dosing calculator or a missed alert in a monitoring dashboard can harm someone before anyone notices the bug. The formal process requires teams to list how the software could harm someone and how they will prevent it before the feature ships.

How Does Medical Software Development Work?

• Intended use and classification come first. The team writes an intended-use statement and determines whether the product qualifies as a medical device. In the EU, Rule 11 of the Medical Device Regulation places software that informs diagnostic or therapeutic decisions in class IIa or higher. The class sets the depth of everything that follows.

• Risk management runs alongside design. Under ISO 14971:2019, the team identifies hazards and estimates their severity and likelihood. It then adds controls and verifies that each one works. The risk file is updated with every change throughout development.

• The lifecycle process scales with software safety class. IEC 62304 sorts software into class A (no injury possible), class B (non-serious injury possible), or class C (death or serious injury possible). Class B adds architecture documentation and integration testing on top of class A, and class C adds detailed design. Software left unclassified is treated as class C by default.

• Traceability links every requirement to a test. Each requirement links to the design element and code that implement it, plus the test that verifies it and any risk control it satisfies. Auditors sample this chain, so many teams generate it from their tools.

• Verification and validation answer separate questions. Verification checks that the software matches its specification. Validation checks that the finished software meets user needs in its intended use, often through usability studies with representative users under IEC 62366-1.

• Change control continues after release. Teams assess every update for regulatory impact, and some changes require a new submission. Connected products also need ongoing vulnerability monitoring, which the FDA requires for "cyber devices" under section 524B of the FD&C Act.

What Tools Do Teams Use for Medical Software Development?

Medical software teams use the same code editors and CI pipelines as any software team, plus three categories of tools that regulated teams depend on.

• Requirements management and traceability. Jama Connect, Siemens Polarion and Ketryx link requirements and risk controls to their tests in one auditable chain. Ketryx runs on Jira, letting teams keep their existing workflow while generating compliance records.

• Electronic quality management systems (eQMS). Greenlight Guru, Qualio, and MasterControl store controlled documents, design and development files, corrective and preventive action (CAPA) records, and training logs in one validated place.

• Software composition analysis and SBOM generation. Snyk, Black Duck, and Finite State inventory third-party components and flag known vulnerabilities. Their output feeds the software bill of materials (SBOM) that FDA cybersecurity rules require for connected devices.

What Are the Key Characteristics of Medical Software Development?

• Documentation is a deliverable. The design and development file in the US (called the design history file before the QMSR) and the technical documentation in the EU are reviewed as closely as the product. Teams plan documentation work into each sprint instead of saving it for release.

• Third-party code is tracked by name. IEC 62304 calls pre-existing components "SOUP" (software of unknown provenance). Every open-source library or commercial component needs a documented list of known anomalies plus a justification for using it.

• Interoperability is planned at the architecture stage. Much medical software exchanges data with electronic health records, so teams design around standards like HL7 FHIR early. Retrofitting an integration later usually means reopening validated parts of the system.

• Privacy is part of the data model. Products that handle patient data for US providers or insurers usually fall under the HIPAA Security Rule through a business associate agreement. EU products treat health data as a special category under GDPR Article 9. Encryption and audit logging are specified as requirements, with their own tests.

• Products stay in service for years. Clinical customers keep validated software running long after a consumer app would have been rebuilt. Teams plan for long-term maintenance of dependencies and operating systems from the first architecture decision.

What Are the Benefits of Medical Software Development?

• Smoother regulatory review. A submission with complete traceability gives reviewers fewer reasons to issue additional-information requests, each of which pauses the review clock.

• Cheaper defect fixes. Hazard analysis at design time catches failure modes while they are still lines in a specification. The same defect found in a clinical pilot costs a redesign plus a new round of verification.

• Evidence that works across markets. Since the FDA's Quality Management System Regulation took effect on February 2, 2026, US device rules incorporate ISO 13485:2016 by reference. One quality system built to ISO 13485 now supports both FDA and EU MDR obligations.

• Faster hospital procurement. Hospital security and compliance reviews often ask for risk files and SBOMs. Teams that already produce these as part of development answer vendor questionnaires with evidence they already have.

• Predictable updates. Formal change control tells the team in advance which updates ship freely and which need regulatory review, so fewer releases are held up by late regulatory questions.

What Are the Challenges of Medical Software Development?

• Documentation slows early iteration. Writing risk entries and test records for every feature adds overhead before product-market fit is proven. Traceability tools cut manual work, but you must validate the tools for their intended use, which adds setup time before the first sprint.

• Classification is often ambiguous. Clinical decision support and wellness features sit close to device boundaries, and a wrong call either overburdens the product or exposes it to enforcement. The FDA's Q-Submission Program provides written feedback before submission, but it costs roughly 70 days of lead time.

• Open-source dependencies carry an ongoing cost. Every SOUP item has to be documented and monitored for vulnerabilities. Updating a library to fix a security issue can trigger re-verification, so teams trade fast patching against the cost of each validation cycle.

• Post-clearance changes need planning. Some modifications require a new submission. For AI-enabled devices in particular, the FDA has detailed guidance on a Predetermined Change Control Plan that pre-authorizes specific changes, but the plan has to be specified in detail upfront and limits the team to the changes it describes.

What Is the Difference Between Medical Software Development and General Software Development?